- In October 2023, Alcon introduced the TOTAL30 Multifocal contact lens, specifically designed for individuals with presbyopia. This innovative lens offers improved visual clarity across varying distances, catering to the specific needs of presbyopia patients. In addition, it is engineered to enhance both comfort and vision quality, providing a long-lasting and comfortable wear experience for users
- In October 2023, XPANCEO, a deep tech startup, secured $40 million in a seed funding round to create the first contact lenses equipped with augmented reality (AR) capabilities. The funding was led by Opportunity Ventures (Asia), based in Hong Kong. The funds will be used to develop the next prototype, which seeks to combine multiple features into a single device
- In June 2023, Bausch + Lomb unveiled the U.S. launch of Infuse Multifocal daily disposable lenses, made from silicone hydrogel (SiHy). These advanced lenses incorporate ProBalance technology, which is designed to maintain optimal comfort throughout the day by supporting the eye's natural moisture balance. Tailored for patients with presbyopia, the lenses address their unique vision requirements by providing clear and stable vision at multiple distances
- In March 2023, The Cooper Companies Inc. introduced its CooperVision MyDay Energys lenses to the U.S. market. These lenses are specifically designed to address the growing issue of digital eye strain, a common condition caused by prolonged screen time. With advanced technology that reduces eye fatigue and discomfort, the MyDay Energys lenses aim to provide relief for individuals experiencing digital eye strain in today's increasingly digital world
- In November 2022, Menicon Co., Ltd. secured approval from China's National Medical Products Administration (NMPA) for its Menicon Z Night, an orthokeratology lens designed to correct vision overnight. This regulatory approval marks a key milestone for the company, allowing it to expand its medical device offerings in the Chinese market. Menicon aims to leverage this approval to boost sales and strengthen its position within China’s growing eye care industry
